Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Metabolic approaches to treatment of melanoma Hersey P; Watts RN; Zhang XD; Hackett JClin Cancer Res 2009[Nov]; 15 (21): 6490-4PURPOSE: Lactate dehydrogenase (LDH) levels in blood of patients with melanoma have proven to be an accurate predictor of prognosis and response to some treatments. Exclusion of patients with high LDH levels from many trials of new treatments has created a need for treatments aimed at patients with high LDH levels. This article reviews the metabolic basis for the association of LDH with prognosis and the treatment initiatives that may be successful in this patient group. EXPERIMENTAL DESIGN: Review of current literature on the topic. RESULTS: A number of new treatment initiatives based on manipulation of metabolic pathways in melanoma cells are now available and await evaluation in well-designed clinical trials. CONCLUSIONS: Different cancers may require different metabolic approaches for effective treatment. In view of the high rate of glycolysis in most melanoma cells, approaches based on inhibition of acid excretion from the cells seem particularly attractive.|Adenosine Triphosphate/metabolism[MESH]|Glycolysis[MESH]|Humans[MESH]|L-Lactate Dehydrogenase/blood[MESH]|Lactic Acid/metabolism[MESH]|Melanoma/*drug therapy/*metabolism[MESH]|Metabolic Networks and Pathways/*drug effects[MESH]|Models, Biological[MESH]|Prognosis[MESH]|Skin Neoplasms/*drug therapy/*metabolism[MESH] |